Hims & Hers Health Inc
Company Profile
Business description
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.
Contact
2269 Chestnut Street
Suite 523
San FranciscoCA94123
USAT: +1 415 851-0195
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
1,637
Stocks News & Analysis
stocks
AI stocks post big gains in Q3. These are the winners and losers
stocks
12 picks for an income portfolio - Q3 2025 update
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,253.60 | 25.70 | -0.28% |
CAC 40 | 7,990.97 | 19.19 | 0.24% |
DAX 40 | 24,408.58 | 30.29 | 0.12% |
Dow JONES (US) | 46,694.97 | 63.31 | -0.14% |
FTSE 100 | 9,499.73 | 20.59 | 0.22% |
HKSE | 26,957.77 | 183.15 | -0.67% |
NASDAQ | 22,941.67 | 161.16 | 0.71% |
Nikkei 225 | 47,950.88 | 6.12 | 0.01% |
NZX 50 Index | 13,531.29 | 42.05 | 0.31% |
S&P 500 | 6,740.28 | 24.49 | 0.36% |
S&P/ASX 200 | 8,956.80 | 19.10 | -0.21% |
SSE Composite Index | 3,882.78 | 20.25 | 0.52% |